Table 2 Clinical outcomes of COVID-19 patients with and without hypertension
From: Clinical outcomes in COVID-19 among patients with hypertension in the Philippine CORONA Study
Outcomes | Hypertensive | Non-hypertensive | p-value |
|---|---|---|---|
(n = 3647) | (n = 7234) |  | |
COVID-19 severity at nadir |  |  |  < 0.001 |
Mild, n (%) | 1714 (47.6%) | 4976 (69.6%) | Â |
Severe/critical, n (%) | 1888 (52.4%) | 2173 (30.4%) | Â |
In-hospital mortality | 874 (24.0%) | 828 (11.5%) |  < 0.001 |
Time to in-hospital mortality in days, median (IQR) | 16 (14) | 14 (12) |  < 0.001 |
Respiratory failure, n (%) | 1005 (27.6%) | 603 (8.3%) |  < 0.001 |
Time to respiratory failure in days, median (IQR) | 5 (4) | 5 (4) | 0.896 |
Duration of MV in days, median (IQR) | 13 (13) | 12 (11) | 0.9136 |
MV dependence ≤ 5 days, n (%) | 131 (13.0%) | 87 (14.5%) | 0.4715 |
MV dependence > 5 days, n (%) | 873 (87.0%) | 515 (85.5%) |  |
Admitted to ICU, n (%) | 1122 (30.8%) | 618 (8.5%) |  < 0.001 |
Time to ICU admission in days, median (IQR) | 5 (4) | 4 (4) | 0.660 |
Length of ICU stay in days, median (IQR) | 15 (13) | 15 (11) | 0.885 |
ICU stay ≤ 7 days, n (%) | 172 (15.3%) | 100 (16.2%) | 0.640 |
ICU stay > 7 days, n (%) | 950 (84.7%) | 518 (83.8%) |  |
Length of hospital staya in days, median (IQR) | 14 (10) | 13 (8) |  < 0.001 |
Hospital stay ≤ 14 days, n (%) | 2058 (56.4%) | 4519 (62.5%) |  < 0.001 |
Hospital stay > 14 days, n (%) | 1589 (43.6%) | 2715 (37.5%) |  |
Neurologic presentation or complication, n (%) | 1084 (29.7%) | 1207 (16.7%) |  < 0.001 |
Neurologic outcomeb |  |  |  < 0.001 |
Full/partial neurologic recovery, n (%) | 700 (81.8%) | 939 (89.5%) | Â |
No recovery, n (%) | 156 (18.2%) | 110 (10.5%) | Â |